Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    October 2021
  1. MCCLUGGAGE WG
    Progress in the pathological arena of gynecological cancers.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:107-114.
    PubMed     Abstract available


  2. WICHMANN IA, Cuello MA
    Obesity and gynecological cancers: A toxic relationship.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:123-134.
    PubMed     Abstract available


  3. BEREK JS, Renz M, Kehoe S, Kumar L, et al
    Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:61-85.
    PubMed     Abstract available


    September 2021
  4. LO HW, Weng SF, Chen HS, Tsai EM, et al
    Pelvic inflammatory disease is associated with ovarian cancer development in women with endometriosis: A cohort study in Taiwan.
    Int J Gynaecol Obstet. 2021 Sep 18. doi: 10.1002/ijgo.13935.
    PubMed     Abstract available


    July 2021
  5. KIM SR, Maganti M, Bernardini MQ, Laframboise S, et al
    Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer.
    Int J Gynaecol Obstet. 2021 Jul 2. doi: 10.1002/ijgo.13813.
    PubMed     Abstract available


    May 2021
  6. PITARCH-MARTINEZ M, Blanco-Elena JA, Robles-Quesada MT, Alberca-Paramo A, et al
    Colonic perforation due to ovarian cancer invasion: An unusual event.
    Int J Gynaecol Obstet. 2021 May 29. doi: 10.1002/ijgo.13770.
    PubMed     Abstract available


  7. D'ALESSANDRO G, Frigerio M, Barra F, Costantini S, et al
    Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.
    Int J Gynaecol Obstet. 2021 May 9. doi: 10.1002/ijgo.13737.
    PubMed     Abstract available


    April 2021
  8. DAHIYA A, Thomas V
    Response: Endometriosis and malignancy-The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Apr 13. doi: 10.1002/ijgo.13688.
    PubMed    


    January 2021
  9. CHEN Q, Wang S, Lang JH
    The impact of lymph node dissection on apparent stage I epithelial ovarian carcinoma: A population-based study.
    Int J Gynaecol Obstet. 2021 Jan 28. doi: 10.1002/ijgo.13627.
    PubMed     Abstract available


  10. DAHIYA A, Sebastian A, Thomas A, George R, et al
    Endometriosis and malignancy: The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Jan 8. doi: 10.1002/ijgo.13585.
    PubMed     Abstract available


    December 2020
  11. LI S, Li H, Tian S, Wu J, et al
    Association between ovarian and breast masses among Chinese women in Chongqing based on ultrasonography screening: A cross-sectional study.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13568.
    PubMed     Abstract available


  12. KIM SR, Kotsopoulos J, Sun P, Bernardini M, et al
    The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer.
    Int J Gynaecol Obstet. 2020 Dec 16. doi: 10.1002/ijgo.13542.
    PubMed     Abstract available


    November 2020
  13. TAKEDA T, Hayashi S, Kobayashi Y, Tsuji K, et al
    Evaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer.
    Int J Gynaecol Obstet. 2020 Nov 22. doi: 10.1002/ijgo.13492.
    PubMed     Abstract available


  14. PERGIALIOTIS V, Papoutsi E, Androutsou A, Tzortzis AS, et al
    Galectins-1,-3,-7,-8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13471.
    PubMed     Abstract available


  15. ESPIAU ROMERA A, Coronado Martin PJ, Choliz Ezquerro M, Cuesta Guardiola T, et al
    Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13473.
    PubMed     Abstract available


    October 2020
  16. TOPRAK S, Sahin EA, Sahin H, Tohma YA, et al
    Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
    Int J Gynaecol Obstet. 2020 Oct 28. doi: 10.1002/ijgo.13449.
    PubMed     Abstract available


  17. AYHAN A, Akilli H
    Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13410.
    PubMed     Abstract available


    July 2020
  18. BULDUKOGLU OC, Turker A, Usubutun A, Salman MC, et al
    Relationship of lymph node status with survival and recurrence among women with endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jul 17. doi: 10.1002/ijgo.13309.
    PubMed     Abstract available


    June 2020
  19. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    PubMed     Abstract available


  20. KHADRAOUI W, Tierney C, Chung S, Mutlu L, et al
    Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jun 7. doi: 10.1002/ijgo.13254.
    PubMed     Abstract available


    May 2020
  21. YOSHIHARA M, Kajiyama H, Tamauchi S, Iyoshi S, et al
    Impact of uterus-preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi-institutional study with propensity score-weighted analysis.
    Int J Gynaecol Obstet. 2020 May 29. doi: 10.1002/ijgo.13244.
    PubMed     Abstract available


  22. BOGANI G, Ditto A, Pinelli C, Lopez S, et al
    Ten-year follow-up study of long-term outcomes after conservative surgery for early-stage ovarian cancer.
    Int J Gynaecol Obstet. 2020 May 16. doi: 10.1002/ijgo.13199.
    PubMed     Abstract available


    April 2020
  23. DARIO MANDATO V, Aguzzoli L
    Management of ovarian cancer during the COVID-19 pandemic.
    Int J Gynaecol Obstet. 2020 Apr 10. doi: 10.1002/ijgo.13167.
    PubMed     Abstract available


    March 2020
  24. JIN L, Zhang Y, Yang W
    Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
    Int J Gynaecol Obstet. 2020 Mar 4. doi: 10.1002/ijgo.13137.
    PubMed     Abstract available


    December 2019
  25. HERNANDEZ-NIETO C, Lee JA, Gonzalez K, Mukherjee T, et al
    Conservative treatment versus surgical excision of ovarian dermoid cysts: Impact on ovarian stimulation and IVF cycle success.
    Int J Gynaecol Obstet. 2019 Dec 11. doi: 10.1002/ijgo.13083.
    PubMed     Abstract available


    November 2019
  26. CHONGYUAN Z, Honglan Z, Yue W, Heng C, et al
    Para-aortic lymphadenectomy below inferior mesenteric artery versus renal vessels in stage IIIC epithelial ovarian cancer: A comparison of surgical outcomes.
    Int J Gynaecol Obstet. 2019 Nov 20. doi: 10.1002/ijgo.13061.
    PubMed     Abstract available


    October 2019
  27. VERMA S, Bakshi D, Sharma V, Sharma I, et al
    Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer.
    Int J Gynaecol Obstet. 2019 Oct 12. doi: 10.1002/ijgo.12997.
    PubMed     Abstract available


    September 2019
  28. SALMAN L, Sabah G, Jakobson-Setton A, Raban O, et al
    Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy.
    Int J Gynaecol Obstet. 2019 Sep 30. doi: 10.1002/ijgo.12986.
    PubMed     Abstract available


  29. DAKHLY DMR, Gaafar HM, Sediek MM, Ibrahim MF, et al
    Diagnostic value of the International Ovarian Tumor Analysis (IOTA) simple rules versus pattern recognition to differentiate between malignant and benign ovarian masses.
    Int J Gynaecol Obstet. 2019 Sep 13. doi: 10.1002/ijgo.12970.
    PubMed     Abstract available


    August 2019
  30. INZANI F, Angelico G, Santoro A, Musarra T, et al
    A new entity in the pathological spectrum of vulvar neoplasms: The first report of a primary endometrioid adenocarcinoma.
    Int J Gynaecol Obstet. 2019 Aug 2. doi: 10.1002/ijgo.12936.
    PubMed     Abstract available


    June 2019
  31. AUEKITRUNGRUENG R, Tinnangwattana D, Tantipalakorn C, Charoenratana C, et al
    Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
    Int J Gynaecol Obstet. 2019 Jun 17. doi: 10.1002/ijgo.12891.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: